Association between β-blocker therapy and outcomes in patients hospitalised with acute exacerbations of chronic obstructive lung disease with underlying ischaemic heart disease, heart failure or hypertension

BACKGROUND: β-Blocker therapy has been shown to improve survival among patients with ischaemic heart disease (IHD) and congestive heart failure (CHF) and is underused among patients with chronic obstructive pulmonary disease (COPD). Evidence regarding the optimal use of β-blocker therapy during an a...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Thorax
Autores principales: Stefan, Mihaela S, Rothberg, Michael B, Priya, Aruna, Pekow, Penelope S, Au, David H, Lindenauer, Peter K
Formato: Artigo
Lenguaje:Inglês
Publicado: 2012
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4454610/
https://ncbi.nlm.nih.gov/pubmed/22941975
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/thoraxjnl-2012-201945
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares